Who owns CONNECT BIOPHARMA HLDGS LTD?
- Ticker: CNTB
- CUSIP Number: g23549101
Tip: Access positions for across all investors
Analyze quarterly positions in Connect Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Connect Biopharma Hldgs stock
Who bought or sold CONNECT BIOPHARMA HLDGS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 4.5M | $11M | -18% | Jun 2026 |
|
| 683 Capital Management | 1.3M | $3.1M | 43% | Jun 2026 |
|
| Boothbay Fund Management | 974k | $2.3M | -23% | Jun 2026 |
|
| BlackRock | 872k | $2.1M | 100% | Jun 2026 |
|
| Perceptive Advisors | 793k | $1.9M | 0% | Jun 2026 |
|
| ADAR1 Capital Management | 700k | $1.7M | -6% | Jun 2026 |
|
| BML Capital Management | 573k | $1.4M | 40% | Jun 2026 |
|
| Silverarc Capital Management | 545k | $1.3M | 100% | Jun 2026 |
|
| Richmond Brothers | 536k | $1.3M | 12% | Jun 2026 |
|
| Knott David M Jr | 445k | $1.1M | 15% | Jun 2026 |
|
| Stonepine Capital Management | 364k | $867k | 18% | Jun 2026 |
|
| Marshall Wace | 336k | $799k | 408% | Jun 2026 |
|
| Geode Capital Management | 258k | $613k | 701% | Jun 2026 |
|
| Two Sigma Investments | 199k | $475k | 320% | Jun 2026 |
|
| Diadema Partners | 197k | $469k | -2% | Jun 2026 |
|
| Burkehill Global Management | 150k | $357k | 0% | Jun 2026 |
|
| Susquehanna International | 120k | $287k | -63% | Jun 2026 |
|
| Vanguard Portfolio Management | 103k | $245k | 100% | Jun 2026 |
|
| Renaissance Technologies | 87k | $208k | -28% | Jun 2026 |
|
| Northern Trust | 83k | $197k | 100% | Jun 2026 |
|
| Simplex Trading | 82k | $195k | 100% | Jun 2026 |
|
| UBS Group | 67k | $158k | 201267% | Jun 2026 |
|
| Persistent Asset Partners | 50k | $119k | -2% | Jun 2026 |
|
| Koa Wealth Management | 50k | $118k | 0% | Jun 2026 |
|
| New York State Common Retirement Fund | 48k | $115k | 100% | Jun 2026 |
|
| Millennium Management | 44k | $104k | -91% | Jun 2026 |
|
| Royal Bank of Canada | 41k | $76k | 1% | Jun 2026 |
|
| Bank of America Corporation | 41k | $97k | 161% | Jun 2026 |
|
| Charles Schwab Investment Management | 37k | $88k | 100% | Jun 2026 |
|
| Sixth Street Partners Management Company | 37k | $88k | 100% | Jun 2026 |
|
| XTX Topco | 29k | $68k | -30% | Jun 2026 |
|
| Bank of New York Mellon | 24k | $57k | 100% | Jun 2026 |
|
| Nuveen | 20k | $47k | 100% | Jun 2026 |
|
| Y-Intercept | 15k | $36k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 13k | $32k | 100% | Jun 2026 |
|
| SmartHarvest Portfolios | 13k | $31k | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 12k | $28k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 11k | $27k | 100% | Jun 2026 |
|
| Monograph Wealth Advisors | 11k | $27k | 0% | Jun 2026 |
|
| Rhumbline Advisers | 11k | $26k | 1308% | Jun 2026 |
|
| Mirae Asset Global Etfs Holdings | 6.9k | $16k | 100% | Jun 2026 |
|
| FNY Investment Advisers | 5.0k | $11k | 0% | Jun 2026 |
|
| Morgan Stanley | 3.6k | $9.4k | 63% | Mar 2026 |
|
| Barclays | 2.9k | $6.9k | 100% | Jun 2026 |
|
| Legal & General Group | 2.4k | $5.7k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 2.3k | $5.4k | 100% | Jun 2026 |
|
| Russell Investments | 1.2k | $2.8k | 100% | Jun 2026 |
|
| Huntington National Bank | 996.00 | $2.4k | 100% | Jun 2026 |
|
| Tower Research Capital | 882.00 | $2.1k | 100% | Jun 2026 |
|
| FMR | 314.00 | $747.006000 | 100% | Jun 2026 |
|
| Sterling Capital Management | 150.00 | $357.000000 | 100% | Jun 2026 |
|
| Caitong International Asset Management | 66.00 | $157.000800 | 100% | Jun 2026 |
|
| SBI Securities | 6.00 | $13.999800 | 0% | Jun 2026 |
|
| Citigroup | 1.00 | $3.000000 | 100% | Mar 2026 |
|
Who sold out of Connect Biopharma Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Propel Bio Management | Mar 2026 | 210k | $554k |
| Citadel Advisors | Mar 2026 | 113k | $295k |
| Jane Street | Mar 2026 | 52k | $136k |
| Simplify Asset Management | Mar 2026 | 52k | $135k |
| Fifth Lane Capital | Mar 2026 | 45k | $118k |
| Goldman Sachs Group | Mar 2026 | 30k | $78k |
| Point72 Asset Management | Mar 2026 | 20k | $52k |
| Virtu Financial | Mar 2026 | 17k | $44k |
| Hrt Financial | Mar 2026 | 15k | $40k |